2,230
Views
4
CrossRef citations to date
0
Altmetric
Articles

pH-sensitive metal-phenolic network capsules for targeted photodynamic therapy against cancer cells

, , , &
Pages 1552-1561 | Received 07 Jul 2017, Accepted 05 Sep 2017, Published online: 18 Sep 2017

References

  • Moan J, Peng Q. An outline of the hundred-year history of PDT. Anticancer Res. 2003;23:3591–3600.
  • Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006;6:535–545.
  • Lovell JF, Liu TWB, Chen J, et al. Activatable photosensitizers for imaging and therapy. Chem Rev. 2010;110:2839–2857.
  • Zhou Z, Song J, Nie L, et al. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev. 2016;45:6597–6626.
  • Von Tappeiner H, Jesionek A. Therapeutische versuche mit fluoreszierenden stoffen. Münch Med Wochenschr. 1903;47:2042–2044.
  • Kelly JF, Snell ME. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol. 1976;115:150–151.
  • Kim BYS, Rutka JT, Chan WCW. Nanomedicine. N Engl J Med. 2010;363:2434–2443.
  • Hubbell JA, Chilkoti A. Chemistry. Nanomaterials for drug delivery. Science. 2012;337:303–305.
  • Mitragotri S, Lahann J. Materials for drug delivery: innovative solutions to address complex biological hurdles. Adv Mater Weinheim. 2012;24:3717–3723.
  • Sun T, Zhang YS, Pang B, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014;53:12320–12364.
  • Probst CE, Zrazhevskiy P, Bagalkot V, et al. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev. 2013;65:703–718.
  • Bajwa N, Mehra NK, Jain K, et al. Pharmaceutical and biomedical applications of quantum dots. Artif Cells Nanomed Biotechnol. 2016;44:758–768.
  • Wang D, Fei B, Halig LV, et al. Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer. ACS Nano. 2014;8:6620–6632.
  • Wei Z, Wu Y, Zhao Y, et al. Multifunctional nanoprobe for cancer cell targeting and simultaneous fluorescence/magnetic resonance imaging. Anal Chim Acta. 2016;938:156–164.
  • Ebrahimi E, Akbarzadeh A, Abbasi E, et al. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG(1000) copolymer. Artif Cell Nanomed Biotechnol. 2016;44:290–297.
  • Ghosh P, Han G, De M, et al. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008;60:1307–1315.
  • Giljohann DA, Seferos DS, Daniel WL, et al. Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl. 2010;49:3280–3294.
  • Daraee H, Eatemadi A, Abbasi E, et al. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 2016;44:410–422.
  • Wu YF, Zhou H, Wei W, et al. Signal amplification cytosensor for evaluation of drug-induced cancer cell apoptosis. Anal Chem. 2012;84:1894–1899.
  • Li HN, Mu YW, Lu JS, et al. Target-cell-specific fluorescence silica nanoprobes for imaging and theranostics of cancer cells. Anal Chem. 2014;86:3602–3609.
  • Li H, Mu Y, Qian S, et al. Synthesis of fluorescent dye-doped silica nanoparticles for target-cell-specific delivery and intracellular MicroRNA imaging. Analyst. 2015;140:567–573.
  • Shen J, Zhao L, Han G. Lanthanide-doped upconverting luminescent nanoparticle platforms for optical imaging-guided drug delivery and therapy. Adv Drug Deliv Rev. 2013;65:744–755.
  • Xiao Z, Ji C, Shi J, et al. DNA self-assembly of targeted near-infrared-responsive gold nanoparticles for cancer thermo-chemotherapy. Angew Chem Int Ed Engl. 2012;51:11853–11857.
  • Li ZX, Barnes JC, Bosoy A, et al. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev. 2012;41:2590–2605.
  • Coll C, Bernardos A, Martínez-Máñez R, et al. Gated silica mesoporous supports for controlled release and signaling applications. Acc Chem Res. 2013;46:339–349.
  • Aznar E, Oroval M, Pascual L, et al. Gated materials for on-command release of guest molecules. Chem Rev. 2016;116:561–718.
  • de la Torre C, Casanova I, Acosta G, et al. Gated mesoporous silica nanoparticles using a double-role circular peptide for the controlled and target-preferential release of doxorubicin in CXCR4-expresing lymphoma cells. Adv Funct Mater. 2015;25:687–695.
  • Tanner P, Baumann P, Enea R, et al. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles. Acc Chem Res. 2011;44:1039–1049.
  • Nicolas J, Mura S, Brambilla D, et al. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev. 2013;42:1147–1235.
  • Mikhaylov G, Mikac U, Magaeva AA, et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat Nanotechnol. 2011;6:594–602.
  • Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65:36–48.
  • Yadav S, Gupta S. Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy. Artif Cells Nanomed Biotechnol. 2015;43:93–102.
  • Bhatia D, Surana S, Chakraborty S, et al. A synthetic icosahedral DNA-based host-cargo complex for functional in vivo imaging. Nat Commun. 2011;2:339–346.
  • Yoo J-W, Irvine DJ, Discher DE, et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov. 2011;10:521–535.
  • Li J, Fan C, Pei H, et al. Smart drug delivery nanocarriers with self-assembled DNA nanostructures. Adv Mater Weinheim. 2013;25:4386–4396.
  • Ejima H, Richardson JJ, Liang K, et al. One-step assembly of coordination complexes for versatile film and particle engineering. Science. 2013;341:154–157.
  • Ju Y, Cui J, Müllner M, et al. Engineering low-fouling and pH-degradable capsules through the assembly of metal-phenolic networks. Biomacromolecules. 2015;16:807–814.
  • Ding X, Xu Q, Liu F, et al. Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation. Cancer Lett. 2004;216:43–54.
  • Lei TC, Glazner GF, Duffy M, et al. Optical properties of hematoporphyrin monomethyl ether (HMME), a PDT photosensitizer. Photodiagn Photodyn Ther. 2012;9:232–242.
  • Petrov AI, Volodkin DV, Sukhorukov GB. Protein-calcium carbonate coprecipitation: a tool for protein encapsulation. Biotechnol Prog. 2005;21:918–925.
  • Chiani M, Norouzian D, Shokrgozar MA, et al. Folic acid conjugated nanoliposomes as promising carriers for targeted delivery of bleomycin. Artif Cells Nanomed Biotechnol. 2017; [2017 Jun 23]; [7 p.]. DOI:10.1080/21691401.2017.1337029
  • Kaittanis C, Santra S, Perez JM. Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. J Am Chem Soc. 2009;131:12780–12791.
  • Santra S, Kaittanis C, Santiesteban OJ, et al. Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy. J Am Chem Soc. 2011;133:16680–16688.
  • Al-Khaza’leh KA, Omar K, Jaafar MS, et al. Effect of acidification on the absorption and fluorescence properties of Sn(IV) chlorin e6 dichloride trisodium salt. Arab J Sci Eng. 2011;36:597–606.
  • Tian J, Ding L, Xu H-J, et al. Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer. J Am Chem Soc. 2013;135:18850–18858.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.